×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LRMR – larimar therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LRMR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
11:41 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "outperform" rating re-affirmed by analysts at William Blair.
11/18
01:35 pm
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
11/18
07:12 am
lrmr
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024 [Yahoo! Finance]
Medium
Report
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024 [Yahoo! Finance]
11/18
07:00 am
lrmr
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
Medium
Report
Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
11/16
01:39 am
lrmr
Is Larimar Therapeutics (LRMR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
Medium
Report
Is Larimar Therapeutics (LRMR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
11/4
11:43 am
lrmr
Wall Street Analysts Think Larimar (LRMR) Could Surge 192.89%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Larimar (LRMR) Could Surge 192.89%: Read This Before Placing a Bet [Yahoo! Finance]
10/31
08:35 am
lrmr
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
10/30
07:00 am
lrmr
Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Medium
Report
Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
07:03 am
lrmr
Form 8-K Larimar Therapeutics, For: Nov 18
Medium
Report
Form 8-K Larimar Therapeutics, For: Nov 18
11/14
05:06 pm
lrmr
Form SC 13G/A Larimar Therapeutics, Filed by: Blue Owl Capital Holdings LP
High
Report
Form SC 13G/A Larimar Therapeutics, Filed by: Blue Owl Capital Holdings LP
11/14
11:41 am
lrmr
Form SC 13G/A Larimar Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Medium
Report
Form SC 13G/A Larimar Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
11/14
09:17 am
lrmr
Form SC 13G/A Larimar Therapeutics, Filed by: Verition Fund Management LLC
Medium
Report
Form SC 13G/A Larimar Therapeutics, Filed by: Verition Fund Management LLC
11/6
02:30 pm
lrmr
Form SC 13G Larimar Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Low
Report
Form SC 13G Larimar Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
10/30
05:04 pm
lrmr
Form 10-Q Larimar Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Larimar Therapeutics, For: Sep 30
10/30
07:04 am
lrmr
Form 8-K Larimar Therapeutics, For: Oct 30
Medium
Report
Form 8-K Larimar Therapeutics, For: Oct 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: